Sign in
Enrolling by invitationNo phase

DETOUR System for Leg Artery Blockages in Peripheral Arterial Disease

Observes the DETOUR System in people with peripheral arterial disease and long leg artery blockages.

Key facts

Who runs it
Endologix
Where
Boston, Cleveland, Delray Beach, Kansas City, New York, Salinas, Storrs, Washington D.C., West Chester, and Wynnewood, United StatesSee the 10 sites
Trial code
Registry title
The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)
Status
Enrolling by invitation
People taking part
450 people, planned
Started
6 Oct 2023
Expected to end
7 Jun 2032
Type of study
Observational, 2 groups
Treatments tested
  • DETOUR System
Record updated
12 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with peripheral arterial disease who have symptoms from blocked or narrowed arteries in the thigh and knee area. Their doctor must judge that they can be treated with the DETOUR System.

Sex
All sexes can join.
Disease stage
Symptomatic femoropopliteal lesions (thigh and knee arteries) from 200 mm to 460 mm long. These are either full long-term blockages (100 mm to 425 mm) or widespread narrowing of more than 70%. People may be poor candidates for surgery or other treatments done inside the blood vessels.

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • -

Who cannot take part

  • -

Where in United States

  • Beth Isreal Deaconess Medical CenterBoston, United StatesEnrolling by invitation
  • Cleveland Clinic - Main CampusCleveland, United StatesEnrolling by invitation
  • Delray Medical CenterDelray Beach, United StatesEnrolling by invitation
  • Saint Luke's Hospital of Kansas CityKansas City, United StatesEnrolling by invitation
  • NYU Langone Medical CenterNew York, United StatesEnrolling by invitation
  • Salinas Valley Memorial HospitalSalinas, United StatesEnrolling by invitation
  • University of ConnecticutStorrs, United StatesEnrolling by invitation
  • MedStar Washington Hospital CenterWashington D.C., United StatesEnrolling by invitation
  • University of PennsylvaniaWest Chester, United StatesEnrolling by invitation
  • Main Line HealthWynnewood, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The purpose of this post-market surveillance study will be to evaluate the real-world use of the DETOUR System in treated patients with symptomatic femoropopliteal lesions from 200 mm to 460 mm in length with chronic total occlusions (100 mm to 425 mm) or diffuse stenosis > 70% who may be considered suboptimal candidates for surgical or alternative endovascular treatments.

The 2 groups in the trial

  • As Treated

    All patients that have received the therapy; patients treated within and outside the IFU criteria subgroups; male and female subgroups; and duplex imaging subgroups for arterial and venous observations.

    Treatment: DETOUR System

  • Imaging Cohort

    Sites that are performing (arterial and venous) duplex ultrasound assessments according to the institution's standard practice will be asked to participate in the DUS imaging cohort. The Imaging sub-study will consist of 55 female and 55 male subjects from these sites. Duplex imaging at 1-, 12-, 24-, and 36-months post-procedure will be collected to assess the endpoints of graft patency and venous thrombus within the vein containing the graft (n=110).

    Treatment: DETOUR System

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Prospective, Single Arm, Registry-based Study to Evaluate the Real-world Use of the DETOUR™ System in US Patients
Plain-language title
DETOUR System for Leg Artery Blockages in Peripheral Arterial DiseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
12 May 2026